furosemide
tamsulosin
nifedipine
diclofenac
B. tamsulosin
blood cells more than pus cells
pus cells if infection was superadded
crystals might appear
all of the above
it is characterized by low urinary magnesium and citrate
magnesium increases renal tubular citrate resorption
diarrheal is a remarkable side effect of magnesium therapy
potassium-magnesium preparations might restore urinary magnesium and citrate levels
1000 - 1300 HU density
5 - 10 mm diameter
lower calyx location
mid ureteral location
patients should be given large amounts of fluids to hasten stones passage
fluids are given to keep the patient well hydrated
the recommended regimen is 2 L of ringer lactate over 2 hours
fluids are contraindicated if desmopressin (DDAVP) was given
physiological saline 0.9%
glycine 1.5%
balanced salt solution
distilled water
formation of triple-phosphate stones
infection with Proteus species
increase production of endogenous uric acid
increase level of uric acid in THE blood
3 6 %
12 15 %
0.4 0.8 %
0.09 0.14 %
frequently caused by loop diuretics
stones are often radiolucent
may be reversed by the use of thiazides
low calcium-to-creatinine ratio predicts stones resolution
by ensuring optimal coupling of the patient to the lithotripter
by running the treatment at a slower rate (60 shocks/min)
by running the treatment with general anesthesia
by all of the above
when stones are multiple and/or recurrent
when stones form in childhood
in cases where nephrocalcinosis and urolithiasis are present
all of the above
dissolving homogenous nucleation
high tendency to form cystine sulfate stones
indicates the amount of dietary protein
post ESWL therapy
short skin-to-stone distance (SSD)
end-stage renal failure
a stone in the upper calyx
the presence of a 30 cm, 4.7 Fr ureteral stent in situ
oral potassium sodium hydrogen citrate granules
increase hydration
allopurinol
all of the above
result from an inherited defect of renal tubular reabsorption of cysteine
characteristically, urate and cysteine stone are radiolucent
cysteine is a dibasic amino acid
on plain X-ray, cysteine stones exhibit ground-glass appearance
should be treated with more analgesics
must undergo metabolic worked out
are unlikely to pass out spontaneously
chemolysis should be tried first
cysteine
urate
calcium
none of the above
ESWL
PCNL
radial nephrolithotomy
pyelolithotomy with ureteral stenting
commonly unilateral
commonly due to repeated infections
urate stones are the second most common cause of staghorn calculi
ESWL monotherapy with ureteral stenting is the ideal treatment
can be placed through perc. nephrostomy
might slip out, especially in females
usually radiopaque
all of the above
ammonium urate
sodium urate
calcium oxalate
calcium phosphate
fungal ball
radiolucent stone
urothelial growth
upper end of DJ ureteral stent
chemical analysis of a recovered stone
hypercalcemia
CT finding
high breakability on ESWL
0 10%
10 20%
20 30%
30 40%
placing the patient in anti-Trendelenburg position
making the puncture under local anesthesia
injection Co2 gas to create a safety space under the diaphragm before puncturing
making the puncture during full expiration
calcium phosphate
calcium oxalate monohydrate
sodium urate
2,8 dihydroxyadenine
lithogenic anion to cation ratio
Randall cut off
saturation index
solubility product
steinstrasse
a stone in ureterocele
fever, leucocytosis, pain
brushite stones
α-Mercaptopropionylglycine
d-Penicillamine
a & b
none of the above
2 days
2 weeks
2 months
4 6 hrs.
Tumor lysis syndrome
hypoparathyroidism
myeloproliferative disorder
Lesch-Nyhan syndrome